Overview - The Centers for Medicare & Medicaid Services (“CMS”) has finalized and proposed several significant changes affecting ...

UnitedHealth reshapes its Medicare Advantage strategy, citing rising healthcare costs and internal financial pressures as key drivers for the shift.

In this new study, investigators sought to measure and attribute out-of-pocket costs to cancer stage and by diagnosis.

AstraZeneca's efforts are paying off as strong U.S. demand, and robust sales of newer cancer, heart and kidney disease ...

Health Secretary Robert F. Kennedy Jr. is promoting his plan to “fix” the system that HHS uses to compensate people injured ...

Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major ...

A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in ...

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 20.2% in the morning session after the company ...

The pharmaceutical industry has a fresh sense of direction after President Donald Trump’s tax-and-spending law included a ...

AstraZeneca ’s AZN second-quarter 2025 core earnings of $1.09 per American depositary share (ADS) came in line with the Zacks ...

A bill centered on prohibiting medical debt from appearing on consumer reports was signed into law by Gov. Matt Meyer.